2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for JAZZ PHARMACEUTICALS INC.

Period 2nd Quarter 2012 Filed Jul 19, 2012 Signed by Jennifer Young - Partner

Official filing
Firm
TARPLIN, DOWNS & YOUNG, LLC
Client
JAZZ PHARMACEUTICALS INC.
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516)

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
ISAAC A FORDJOUR —
LINDA E TARPLIN Means; Cmte. Staff, Sen. Cmte. on Finance
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2236 (112th), H.R. 5334 (112th), S. 2516 (112th), S. 3187 (112th), H.R. 3988 (112th), S. 2289 (112th), H.R. 4087 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.